Nine new recommendations for the management of Behcet's disease have been issued by the European League Against Rheumatism, based on a review of literature dating from 1966 through 2006.
Although the guidelines relating to the dermatologic, oral, ocular, and joint manifestations of Behcet's disease (BD) were mostly evidence-based, the recommendations on treating BD-associated vascular, neurologic, and gastrointestinal problems were "mainly based on observational studies, retrospective analyses, and clinical experience of the experts" who wrote the report (Ann. Rheum. Dis. 2008 Jan. 31 [doi: 10.1136 / ard.2007.080432]).
Dr. Yusuf Yazici, who was not on the task force, ...